Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Liporaxel (paclitaxel oral)
i
Other names:
DHP107, DHP-107, RMX-3001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Dae Hwa, HaiHe Biopharma
Drug class:
Bcl2 inhibitor, Tubulin inhibitor
Related drugs:
‹
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
APG1244 (2)
BGB-11417 (1)
oral paclitaxel/encequidar (1)
AT 101 (1)
S55746 (1)
A166 (6)
CMG901 (4)
TPX-4589 (3)
HZX-02-059 (2)
XMT-1660 (2)
DJ 927 (2)
vinblastine (2)
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
APG1244 (2)
BGB-11417 (1)
oral paclitaxel/encequidar (1)
AT 101 (1)
S55746 (1)
A166 (6)
CMG901 (4)
TPX-4589 (3)
HZX-02-059 (2)
XMT-1660 (2)
DJ 927 (2)
vinblastine (2)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
HER-2 negative
HER2 Negative Breast Cancer
HER-2 negative
HER2 Negative Breast Cancer
paclitaxel oral
Sensitive: C2 – Inclusion Criteria
paclitaxel oral
Sensitive
:
C2
paclitaxel oral
Sensitive: C2 – Inclusion Criteria
paclitaxel oral
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login